Novel oral anticoagulant vs. warfarin in elderly atrial fibrillation patients with normal, mid‐range, and reduced left ventricular ejection fraction

AIMS: Patients with concomitant atrial fibrillation (AF) and reduced left ventricular ejection fraction (LVEF) have poor prognosis. Outcomes of novel oral anticoagulant (NOAC) in elderly AF patients with normal, mid‐range, and reduced LVEF were investigated. METHODS AND RESULTS: Data were retrieved...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Victor Chien‐Chia, Wang, Chun‐Li, Lee, Cheng‐Hung, Chen, Yu‐Ling, Tu, Hui‐Tzu, Wu, Michael, Kuo, Chang‐Fu, Chen, Shao‐Wei, Huang, Yu‐Tung, Wen, Ming‐Shien, Chang, Shang‐Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524083/
https://www.ncbi.nlm.nih.gov/pubmed/32677373
http://dx.doi.org/10.1002/ehf2.12890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524083/
https://www.ncbi.nlm.nih.gov/pubmed/32677373
http://dx.doi.org/10.1002/ehf2.12890

Ejemplares similares